Skip to content
  • Insights Newsletter

    Always Be a Step Ahead

    Learn the important healthcare trends that could affect you in advance. Get expert analysis and discover the innovative ideas that are helping businesses overcome today's challenges.

    Subscribe to AMI's Insights Newsletter Today.

     

  • Login
  • Contact
  • Subscribe
  • Insights Newsletter

    Always Be a Step Ahead

    Learn the important healthcare trends that could affect you in advance. Get expert analysis and discover the innovative ideas that are helping businesses overcome today's challenges.

    Subscribe to AMI's Insights Newsletter Today.

     

  • Login
Access Market IntelligenceAccess Market Intelligence
  • Menu
  • About
    • Dr. Randy Vogenberg
    • John Santilli
    • News Announcements
    • Contact
  • Shop Reports
    • Filter By
      • Discounted
      • Latest Releases
    • Report Topic or Type
      • Ebooks
      • Provider Trends
      • Payor Trends
      • Purchaser Trends
      • Market Access & Distribution
  • Solutions
    • Data and Intelligence Platforms
      • Specialty Pharmacy Database
      • Employer Sales Initiatives
    • Advisory and Consulting Services
      • Virtual Advisory Board for Healthcare
      • Strategy Development
      • Health Benefit Training
      • Custom Market Research
  • Resources
    • Insights Blog
    • Sample Report
    • Free Publications
  • Specialty Pharmacy Database
    • Blog – Specialty Pharmacy
    • SPD Case Study
    • SPD Request for Information
  • $0.00 0
    • No products in the cart.

  • Shop
  • 0

    Cart

    No products in the cart.

Tag Archives: performace-based

Clinical Collaborations, Health Insurance, Pharmaceutical, Specialty Drug

Highmark’s Strategy to Contain Drug Costs Includes an Increasing Number of Outcome-Based Contracts

Posted on August 20, 2020 by John Santilli
20
Aug

Pharmaceutical manufacturers and payers have developed a number of agreements under which reimbursement is contingent on specific outcomes over the last few years

Continue reading →
Posted in Clinical Collaborations, Health Insurance, Pharmaceutical, Specialty Drug  |  Tagged agreement, AstraZeneca, autoimmuneinflammatory, Blue Cross, Blue Shield, Boehringer Ingelheim, Cimzia, commercial member, contract, COPD, Crohn's, diabetes, Highmark, outcomes-based, performace-based, psoriasis, rheumatoid arthritis, risk sharing, Takeda, UCB, value-based

Copyright 2021 © Access Market Intelligence. All Rights Reserved  |  Terms of Service 

  • Login
  • Home
  • Reports
    • View Samples
    • What’s New
    • On Sale
    • eBooks
    • By Market
      • Payor
      • Purchaser
      • Provider
      • Market Access & Distribution
  • Services
    • Virtual Advisory Board
    • Strategy Development
    • Health Benefit Training
    • Market Research
  • Data Solutions
    • Specialty Pharmacy Database (SPD)
    • Employer Sales Initiatives
  • Resources
    • Blog
    • Free Downloads
  • About
    • Contact

Login

Lost your password?

Register